Mercy BioAnalytics, Inc.
Evan Ferrell has over 20 years of work experience with various companies. Evan currently serves as a Senior Program Manager at Mercy BioAnalytics, Inc. Evan previously worked at Quanterix in several positions, including Senior Program Manager, Project Manager, Manager of Assay Development, Scientist, Associate Scientist, and Senior Research Associate. Evan was also a consultant at Aviir, Inc., a Research Associate III at Pathogenetix, a Product Development/Manufacturing Associate at Exact Sciences, and a Graduate Student at the University of Wisconsin-Madison. Additionally, they worked as an Intern at Alpha Beta Technology, Inc. Throughout their career, Ferrell has gained expertise in transcriptional regulation, global virulence factor regulator, and assay development.
Evan Ferrell earned a Bachelor of Science in Biotechnology from Worcester Polytechnic Institute in 1999. Later, they pursued a Master of Science degree in Cell and Molecular Biology from the University of Wisconsin-Madison in 2002. In 2019, they obtained a certification in Project Management Professional (PMP) from the Project Management Institute.
This person is not in any teams
Mercy BioAnalytics, Inc.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018.